Recent Events & Catalysts

2 Reasons to Avoid BMRN and 1 Stock to Buy Instead

Yahoo · today

Citigroup Maintains Buy on BioMarin Pharmaceutical, Raises Price Target to $76

Benzinga · 1d ago

Collect 9.8% On VRTX Stock Now, And Still Keep 15% Of Upside

Yahoo · 1d ago

FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo

Yahoo · 3d ago

BioMarin Pharmaceutical (BMRN) Following Its VOXZOGO FDA Filing And The Case For Undervaluation

Yahoo · 4d ago

1 of Wall Street’s Favorite Stocks with Competitive Advantages and 2 We Avoid

Yahoo · 4d ago

U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia

Yahoo · 4d ago

MioMarin Pharmaceuticals Receives FDA Supplemental New Drug Application Approval For Vosoritide To Treat Pediatric Achondroplasia

Benzinga · 4d ago

Other events, Financial statements and exhibits

Filed 2026-07-13 · 5d ago

Departure/appointment of directors or officers, Submission of matters to a vote of security holders

Filed 2026-06-04 · 44d ago

Results of operations (earnings release), Financial statements and exhibits

Filed 2026-05-04 · 75d ago · Material

Entry into a material agreement, Completion of acquisition or disposition of assets, Creation of a direct financial obligation (new debt), Regulation FD disclosure, Financial statements and exhibits

Filed 2026-04-27 · 82d ago · Material

Other events

Filed 2026-04-23 · 86d ago